(Total Views: 462)
Posted On: 06/19/2018 11:19:23 AM
Post# of 89168

$AMBS The formation of Elto Pharma and MANF Therapeutics added to the already established wholly-owned subsidiary Cutanogen Corporation which is developing Engineered Skin Substitute (ESS) initially for the treatment of life-threatening pediatric severe burns.
https://financialstrend.com/two-themes-could-...46629.html
https://financialstrend.com/two-themes-could-...46629.html


Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼